Arginine-related guanidino compounds and nitric oxide synthase in the brain of ornithine transcarbamylase deficient spf mutant mouse: Effect of metabolic arginine deficiency

Neuroscience Letters

Volumn 215, Issue 3, 1996, Pages 153-156

  Ratnakumari, L ^a   Qureshi, I A ^a   Butterworth, R F ^b   Marescau, B ^c   De Deyn, P P ^c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Brain; Congenital hyperammonemia; Guanidines; Metabolic arginine deficiency; Nitric oxide synthase

Indexed keywords

4 GUANIDINOBUTYRIC ACID; ALPHA N ACETYLARGININE; ARGININIC ACID; CREATININE; GUANIDINOACETIC ACID; NITRIC OXIDE SYNTHASE; ORNITHINE CARBAMOYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME DEFICIENCY; HYPERAMMONEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030582438     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12975-X     Document Type: Article

References (23)

1. [1] Bredt, D.S. and Snyder, S.H., Isolation of nitric oxide synthetase, a calmodulin requiring enzyme, Proc. Natl. Acad. Sci. USA, 87 (1990) 682-685.
2. [2] Cohen, B.D., Stein. I.M. and Bonas, J.E., Guanidinosuccinic aciduria in ureamia. A possible alternate pathway for urea synthesis, Am. J. Med., 45 (1968) 63-68.
3. [3] De Deyn, P.P., Marescau, B., Lornoy, W., Becaus, I. and Lowenthal, A., Guanidino compounds in ureamic dialysed patients, Clin. Chim. Acta, 157 (1986) 143-150.
4. [4] Featherston, W.R., Rogers, Q.R. and Freedland, R.A., Relative importance of kidney and liver in synthesis of arginine, Am. J. Physiol., 224 (1973) 127-129.
5. [5] Inoue, I., Gushiken, T., Kobayashi, K. and Saheki, T., Accumulation of large neutral amino acids in the brain of sparse-fur mice at hyperammonemic state, Biochem. Med. Metab. Biol., 38 (1987) 378-386.
6. [6] Knowles, R.G. and Moncada, S., Nitric oxide synthases in mammals, Biochem. J., 298 (1994) 249-258.
7. [7] Leonard, T.O. and Lydic, R., Nitric oxide synthase inhibition decreases partial acetylcholine release, NeuroReport, 6 (1995) 1525-1529.
8. [8] Levin, B., Oberholzer, V.G. and Sinclair, R.L., Biochemical investigation of hyperammonaemia, Lancet, 2 (1969) 170-174.
9. [9] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with the folin-phenol reagent. J. Biol. Chem., 193 (1951) 265-275.
10. [10] Marescau, B., Qureshi, I.A., De Deyn, P., Letarte, J., Ryba, R. and Lowenthal, A., Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy. Clin. Chim. Acta, 146 (1985) 21-27.
11. [11] Marescau, B., Deshmukh, D.R., Kockx, M., Possemiers, I., Qureshi, I.A., Wiechert, P. and De Deyn, P.P., Guanidino compounds in serum, urine, liver, kidney and brain of man and some urotelic animals, Metabolism, 41 (1992) 526-532.
12. [12] Qureshi, I.A., Letarte, J. and Quellet, R., Ornithine transcarbamylase deficiency in mutant mice: 1. Studies on the characterization of enzyme defect and suitability as animal model of human disease, Pediatr. Res., 13 (1979) 807-811.
13. [13] Qureshi, I.A., Letarte, J. and Quellet, R., Expression of ornithine transcarbamylase deficiency in the small intestine and colon of sparse-fur mutant mice, J. Pediatr. Gastroenterol. Nutr., 4 (1985) 118-124.
14. [14] Qureshi, I.A., Marescau, B., Levy, M., De Deyn, P.P., Letarte, J. and Lowenthal, A., Serum and urinary guanidino compounds in sparse-fur mutant mice with ornithine transcarbamylase deficiency. In A. Mori, B.D. Cohen and H. Koide (Eds.), Guanidines 2, Plenum Press, New York, 1989, pp. 45-51.
15. [15] Ratnakumari, L., Qureshi, I.A. and Butterworth, R.F., Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice, Biochem. Biophys. Res. Commun., 184 (1992) 746-751.
16. [16] Ratnakumari, L., Qureshi, I.A. and Butterworth, R.F., Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia, Biochem. Pharmacol., 45 (1993) 137-146.
17. 3H]MK 801 binding sites in brain in congenital ornithine transcarbamylase deficiency, Metab. Brain Dis., 10 (1995) 249-255.
18. 2 receptor changes in congenital ornithine transcarbamylase deficiency, Pediatr. Res., 40 (1996) 25-28.
19. [19] Seiler, N., Grauffel, C., Daune-Anglard, G., Sarhan, S. and Knodgen, B., Decreased hyperammonemia and orotic aciduria due to inactivation of ornithine aminotransferase in mice with a hereditary abnormal ornithine carbamoyltransferase, J. Inher. Metab. Dis., 17 (1994) 691-703.
20. 15N-arginine to guanidino compounds. In A. Mori., B.D. Cohen and A. Lowenthal (Eds.), Guanidines, Plenum Press, New York, 1985, pp. 71-81.
21. [21] Southam, E., East, S.J. and Garthwaite, J., Excitatory amino acid receptor coupled to nitric oxide/cyclic AMP pathway in rat cerebellum during development, J. Neurochem., 56 (1991) 2072-2081.
22. [22] Watanabe, Y., Shindo, S. and Mori, A., Developmental changes in guanidino compound levels in mouse organs. In A. Mori, B.D. Cohen and A. Lowenthal (Eds.), Guanidines, Plenum Press, New York, 1985, pp. 49-58.
23. [23] Windmueller, H.G. and Spaeth, A.E., Source and fate of circulating citrulline, Am. J. Physiol., 241 (1981) E473-E480.